Donald R. Schwartz

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

Donald R. Schwartz, Sharon L. R. Kardia, Kerby Shedden et al. · PubMed · 2002 · 430 citations

Veterinary Medicine, Oncology, Pathology +17

Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells

Cheryl A. Sherman‐Baust, Ashani T. Weeraratna, Letícia Batista Azevedo Rangel et al. · Cancer Cell · 2003 · 345 citations · Full text

Medicine, Cell Biology, Oncology +16

Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.

Letícia Batista Azevedo Rangel, Rachana Agarwal, Theresa D’Souza et al. · PubMed · 2003 · 341 citations

Medicine, Molecular Biology, Oncology +15

Mouse Model of Human Ovarian Endometrioid Adenocarcinoma Based on Somatic Defects in the Wnt/β-Catenin and PI3K/Pten Signaling Pathways

Rong Wu, Neali Hendrix-Lucas, Rork Kuick et al. · Cancer Cell · 2007 · 312 citations · Full text

Medicine, Cancer Biology, Oncology +16

FGF‐20 and DKK1 are transcriptional targets of β‐catenin and FGF‐20 is implicated in cancer and development

Mario Chamorro, Donald R. Schwartz, Alin Vonica et al. · The EMBO Journal · 2004 · 299 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12